Literature DB >> 16765337

Redox signaling in hypertension.

Tamara M Paravicini1, Rhian M Touyz.   

Abstract

Diseases such as hypertension, atherosclerosis and diabetes are associated with vascular functional and structural changes including endothelial dysfunction, altered contractility and vascular remodeling. Cellular events underlying these processes involve changes in vascular smooth muscle cell (VSMC) growth, apoptosis/anoikis, cell migration, inflammation, and fibrosis. Many stimuli influence cellular changes, including mechanical forces, such as shear stress, and vasoactive agents, of which angiotensin II (Ang II) appears to be amongst the most important. Ang II mediates many of its pleiotropic vascular effects through NAD(P)H oxidase-derived reactive oxygen species (ROS). Mechanical forces, comprising both unidirectional laminar and oscillatory shear, are increasingly being recognized as important inducers of vascular NO and ROS generation. In general, laminar flow is associated with upregulation of eNOS and NO production and increased expression of antioxidants glutathione peroxidase and superoxide dismutase, thereby promoting a healthy vascular wall and protecting against oxidative vascular injury. On the other hand, oscillatory shear is linked to increased ROS production with consequent oxidative damage, as occurs in hypertension. ROS function as important intracellular and intercellular second messengers to modulate many downstream signaling molecules, such as protein tyrosine phosphatases, protein tyrosine kinases, transcription factors, mitogen-activated protein kinases, and ion channels. Induction of these signaling cascades leads to VSMC growth and migration, expression of pro-inflammatory mediators, and modification of extracellular matrix. In addition, ROS increase intracellular free Ca(2+) concentration, a major determinant of vascular reactivity. ROS influence signaling molecules by altering the intracellular redox state and by oxidative modification of proteins. In physiological conditions, low concentrations of intracellular ROS play an important role in normal redox signaling involved in maintaining vascular function and integrity. Under pathological conditions ROS contribute to vascular dysfunction and remodeling through oxidative damage. The present review describes some of the redox-sensitive signaling pathways that are involved in the functional and structural vascular changes associated with hypertension.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16765337     DOI: 10.1016/j.cardiores.2006.05.001

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  169 in total

1.  Simvastatin induces a central hypotensive effect via Ras-mediated signalling to cause eNOS up-regulation.

Authors:  Wen-Han Cheng; Wen-Yu Ho; Chien-Feng Chang; Pei-Jung Lu; Pei-Wen Cheng; Tung-Chen Yeh; Ling-Zong Hong; Gwo-Ching Sun; Michael Hsiao; Ching-Jiunn Tseng
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

2.  Effect of AT1 receptor blockade on intermittent hypoxia-induced endothelial dysfunction.

Authors:  Noah J Marcus; Nathan R Philippi; Cynthia E Bird; Yu-Long Li; Harold D Schultz; Barbara J Morgan
Journal:  Respir Physiol Neurobiol       Date:  2012-06-21       Impact factor: 1.931

Review 3.  Candidate genes for hypertension: insights from the Dahl S rat.

Authors:  Nathan P Rudemiller; David L Mattson
Journal:  Am J Physiol Renal Physiol       Date:  2015-04-15

Review 4.  Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling.

Authors:  Paul D Ray; Bo-Wen Huang; Yoshiaki Tsuji
Journal:  Cell Signal       Date:  2012-01-20       Impact factor: 4.315

5.  Uric acid and insulin sensitivity and risk of incident hypertension.

Authors:  John P Forman; Hyon Choi; Gary C Curhan
Journal:  Arch Intern Med       Date:  2009-01-26

Review 6.  The role of interleukin 18 in the pathogenesis of hypertension-induced vascular disease.

Authors:  Simon W Rabkin
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2009-03

7.  Estrogen metabolism by cytochrome P450 1B1 modulates the hypertensive effect of angiotensin II in female mice.

Authors:  Brett L Jennings; L Watson George; Ajeeth K Pingili; Nayaab S Khan; Anne M Estes; Xiao R Fang; Frank J Gonzalez; Kafait U Malik
Journal:  Hypertension       Date:  2014-04-28       Impact factor: 10.190

8.  Role of NADPH oxidase and iNOS in vasoconstrictor responses of vessels from hypertensive and normotensive rats.

Authors:  Y Alvarez; A M Briones; R Hernanz; J V Pérez-Girón; M J Alonso; M Salaices
Journal:  Br J Pharmacol       Date:  2007-11-12       Impact factor: 8.739

Review 9.  The emerging role of cardiovascular risk factor-induced mitochondrial dysfunction in atherogenesis.

Authors:  Paolo Puddu; Giovanni M Puddu; Eleonora Cravero; Susanna De Pascalis; Antonio Muscari
Journal:  J Biomed Sci       Date:  2009-12-09       Impact factor: 8.410

10.  Fructose and vitamin C intake do not influence risk for developing hypertension.

Authors:  John P Forman; Hyon Choi; Gary C Curhan
Journal:  J Am Soc Nephrol       Date:  2009-01-14       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.